Hypoglycemia in patients with type 2 diabetes using concomitant exenatide BID and long-acting insulin therapy

Use of Twice-Daily Exenatide in Basal Insulin–Treated Patients With Type 2 Diabetes

(2013) John B. Buse et al.   ANNALS OF INTERNAL MEDICINE

Safety and Efficacy of Exenatide in Combination with Insulin in Patients with Type 2 Diabetes Mellitus

(2013) Catherine Sheffield et al.   Endocrine Practice

Glucagon-Like Peptide-1 Analog and Insulin Combination Therapy in the Management of Adults with Type 2 Diabetes Mellitus

(2010) Maria Tzefos et al.   ANNALS OF PHARMACOTHERAPY

Exenatide added to insulin therapy: A retrospective review of clinical practice over two years in an academic endocrinology outpatient setting

(2009) Nancy M. Yoon et al.   CLINICAL THERAPEUTICS

Exenatide efficacy and safety: a systematic review

(2009) S. L. Norris et al.   DIABETIC MEDICINE

Initiating and Intensifying Insulin Therapy in Type 2 Diabetes Mellitus

(2008) Joseph Tibaldi   AMERICAN JOURNAL OF MEDICINE

Medical Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy: A consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes

(2008) D. M. Nathan et al.   DIABETES CARE

Validation of ICD-9-CM coding algorithm for improved identification of hypoglycemia visits

(2008) Adit A Ginde et al.   BMC Endocrine Disorders